Brief: Natco Pharma Completed USFDA Inspection Of Co’S Compliance To Pharmacovigilance Requirements
02/11/2023 03:32
Nov 2 (Reuters) - Natco Pharma Ltd NATP.NS :
* SUCCESSFULLY COMPLETED USFDA INSPECTION OF CO’S COMPLIANCE TO
PHARMACOVIGILANCE
REQUIREMENTS
* USFDA INSPECTION COMPLETED TO PHARMACOVIGILANCE REQUIREMENTS WITH ZERO
OBSERVATIONS
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees